| Higher specificity of the activity of low molecular weight fucoidan for thrombin-induced platelet aggregation | |
| Zhu, Zhixiang; Zhang, Quanbin2; Chen, Lihong; Ren, Shuang; Xu, Pingxing; Tang, Yu; Luo, Dali1 | |
| 2010-05-01 | |
| 发表期刊 | THROMBOSIS RESEARCH
 |
| 卷号 | 125期号:5页码:419-426 |
| 文章类型 | Article |
| 摘要 | Algal fucoidans possess a wide variety of biological activities, including anticoagulation and antithrombosis, making them potential candidates for clinical use. We assessed the antiaggregant, anticoagulant and antithrombotic activities and the underlying mechanism of the low-and high-molecular weight fucoidans from the seaweed Laminaria japonica of Qingdao, China (F-Q and HMWF-Q). In the platelets of rats and humans, HMWF-Q demonstrated a pro-aggregation response, whereas F-Q (like the commercially purchased fucoidan (F-S) and heparin), showed an inhibitory effect on thrombin-induced aggregation with an IC(50) of 8 mu g/mL, approximately five times lower than those of F-S and heparin. In the activated partial thromboplastin time test, F-Q (40 mu g/mL) demonstrated less potent effect than F-S (40 mu g/mL) and heparin (7 mu g/mL); 162 +/- 2.4 s vs. 250 +/- 13.2 s and > 300 s, p < 0.01, respectively. It was also less effective than F-S on inhibiting thrombin catalyzed fibrinogen cleavage (IC(50) 10 mu g/mL vs. 2.8 mu g/mL) in vitro and rat thrombosis in vivo at 3 mg/kg (i.v.). The inhibitory effects of F-Q and heparin on thrombin activity were strikingly enhanced by either antithrombin (AT) or heparin cofactor II (HCII). A direct interaction of F-S with thrombin, and F-Q or heparin with AT was demonstrated in both fluorescence quenching and PAGE analysis. Additionally, a pro-aggregation effect and an enhancement of thrombin activity were also observed with F-S, but not with F-Q or heparin, treatment. These results indicate that F-Q inhibits thrombin via activation of AT and HCII, whereas F-S mainly interacts directly with thrombin. Importantly, F-Q shows a higher specificity for hypoaggregation and a weaker effect for anticoagulant profiles than heparin and F-S. Therefore, F-Q could be a promising candidate for the treatment of thrombosis-related cardiovascular diseases. (C) 2010 Elsevier Ltd. All rights reserved. |
| 关键词 | Fucoidan Heparin Aggregation Coagulation Thrombin Thrombosis |
| DOI | 10.1016/j.thromres.2010.02.011 |
| 收录类别 | SCI |
| 语种 | 英语 |
| WOS记录号 | WOS:000277209200010 |
| 引用统计 | |
| 文献类型 | 期刊论文 |
| 条目标识符 | http://ir.qdio.ac.cn/handle/337002/32735 |
| 专题 | 海洋生物技术研发中心 |
| 作者单位 | 1.Capital Med Univ, Sch Chem Biol & Pharmaceut Sci, Dept Pharmacol, Beijing 100069, Peoples R China 2.Chinese Acad Sci, Inst Oceanol, Qingdao 266071, Peoples R China |
| 推荐引用方式 GB/T 7714 | Zhu, Zhixiang,Zhang, Quanbin,Chen, Lihong,et al. Higher specificity of the activity of low molecular weight fucoidan for thrombin-induced platelet aggregation[J]. THROMBOSIS RESEARCH,2010,125(5):419-426. |
| APA | Zhu, Zhixiang.,Zhang, Quanbin.,Chen, Lihong.,Ren, Shuang.,Xu, Pingxing.,...&Luo, Dali.(2010).Higher specificity of the activity of low molecular weight fucoidan for thrombin-induced platelet aggregation.THROMBOSIS RESEARCH,125(5),419-426. |
| MLA | Zhu, Zhixiang,et al."Higher specificity of the activity of low molecular weight fucoidan for thrombin-induced platelet aggregation".THROMBOSIS RESEARCH 125.5(2010):419-426. |
| 条目包含的文件 | ||||||
| 文件名称/大小 | 文献类型 | 版本类型 | 开放类型 | 使用许可 | ||
| Higher specificity o（1114KB） | 期刊论文 | 出版稿 | 限制开放 | ODC PDDL | 浏览 | |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论